Location: Princeton, NJ
CIK: 0001907884 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $1.565B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| COGT | COGENT BIOSCIENCES INC | 6,165,223 | $219M | 14.0% | $7.97 | +252.9% | COM | 19240Q201 |
| VERA | VERA THERAPEUTICS INC | 3,433,051 | $174M | 11.1% | $21.50 | +65.2% | CL A | 92337R101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 8,050,959 | $169M | 10.8% | $17.75 | -1.7% | COM | 87164F105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 5,943,180 | $161M | 10.3% | $29.50 | -10.7% | COM NEW | 15117B202 |
| PCVX | VAXCYTE INC | 2,922,335 | $135M | 8.6% | $77.50 | -42.3% | COM | 92243G108 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 9,366,526 | $73.06M | 4.7% | $6.82 | +5.9% | COM | 09058V103 |
| BEAM | BEAM THERAPEUTICS INC | 2,440,214 | $67.64M | 4.3% | $25.65 | -0.5% | COM | 07373V105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,470,541 | $45.76M | 2.9% | $16.74 | +63.9% | COM | 92790C104 |
| TYRA | TYRA BIOSCIENCES INC | 1,564,492 | $41.13M | 2.6% | $13.36 | +37.5% | COM | 90240B106 |
| CGON | CG ONCOLOGY INC | 945,830 | $39.27M | 2.5% | $34.56 | +19.7% | COM | 156944100 |
| CTMX | CYTOMX THERAPEUTICS INC | 8,966,077 | $38.2M | 2.4% | $3.02 | +26.0% | COM | 23284F105 |
| NRIX | NURIX THERAPEUTICS INC | 1,970,357 | $37.38M | 2.4% | $12.80 | +12.3% | COM | 67080M103 |
| WVE | WAVE LIFE SCIENCES LTD | 2,169,105 | $36.87M | 2.4% | $4.64 | +119.0% | SHS | Y95308105 |
| CGEM | CULLINAN THERAPEUTICS INC | 3,114,132 | $32.23M | 2.1% | $11.02 | -18.1% | COM | 230031106 |
| IMCR | IMMUNOCORE HLDGS PLC | 856,462 | $29.73M | 1.9% | $29.77 | — | ADS | 45258D105 |
| MBX | MBX BIOSCIENCES INC | 934,799 | $29.48M | 1.9% | $13.37 | +81.5% | COM | 55287L101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 1,810,954 | $29.25M | 1.9% | $13.44 | -1.4% | COM | 483497103 |
| BEAM | BEAM THERAPEUTICS INC | 937,000 | $25.97M | 1.7% | $25.65 | -0.5% | Call | 07373V105 |
| APLS | APELLIS PHARMACEUTICALS INC | 908,607 | $22.82M | 1.5% | $23.34 | +0.5% | COM | 03753U106 |
| — | DYNAVAX TECHNOLOGIES CORP | 1,375,632 | $21.16M | 1.4% | $12.15 | — | COM NEW | 268158201 |
| BNR | BURNING ROCK BIOTECH LTD | 994,883 | $20.05M | 1.3% | $6.40 | — | SPONSORED ADS | 12233L206 |
| TVTX | TRAVERE THERAPEUTICS INC | 517,884 | $19.79M | 1.3% | $15.29 | +112.6% | COM | 89422G107 |
| PHVS | PHARVARIS N V | 640,395 | $17.77M | 1.1% | $22.18 | +8.6% | COM | N69605108 |
| ENGN | ENGENE HOLDINGS INC | 1,492,898 | $13.48M | 0.9% | $7.65 | +4.7% | COM | 29286M105 |
| RLAY | RELAY THERAPEUTICS INC | 1,424,259 | $12.05M | 0.8% | $4.42 | +61.6% | COM | 75943R102 |
| BHVN | BIOHAVEN LTD | 702,884 | $7.936M | 0.5% | $12.39 | 0.0% | COM | G1110E107 |
| DSGN | DESIGN THERAPEUTICS INC | 784,606 | $7.36M | 0.5% | $4.65 | +68.6% | COM | 25056L103 |
| STRO | SUTRO BIOPHARMA INC | 479,590 | $5.549M | 0.4% | $9.49 | 0.0% | COM SHS | 869367201 |
| AMRN | AMARIN CORP PLC | 389,273 | $5.432M | 0.3% | $16.22 | — | SPONSORED ADR | 023111404 |
| GERN | GERON CORP | 3,456,318 | $4.562M | 0.3% | $2.44 | -48.5% | COM | 374163103 |
| CLYM | CLIMB BIO INC | 1,028,341 | $4.113M | 0.3% | $2.66 | -9.9% | COM | 28658R106 |
| CRBU | CARIBOU BIOSCIENCES INC | 2,503,302 | $3.98M | 0.3% | $3.41 | -38.5% | COM | 142038108 |
| OMER | OMEROS CORP | 200,000 | $3.436M | 0.2% | — | — | Put | 682143102 |
| EVMN | EVOMMUNE INC | 185,482 | $3.175M | 0.2% | $18.78 | 0.0% | COM SHS | 30054Y107 |
| PRQR | PROQR THRAPEUTICS N V | 1,566,317 | $3.164M | 0.2% | $3.18 | -26.4% | SHS EURO | N71542109 |
| ALEC | ALECTOR INC | 2,000,000 | $3.12M | 0.2% | $1.77 | 0.0% | COM | 014442107 |
| PRLD | PRELUDE THERAPEUTICS INC | 788,867 | $2.288M | 0.1% | $1.69 | 0.0% | COM | 74065P101 |